Our working model is that upon infection of cells in an IFN-induced antiviral state, although virus transcription and protein synthesis are initially severely affected (Carlos et al., 2005, 2007), PIV5 targets STAT1 for proteasome-mediated degradation. The gene discussed is STAT1; the disease is infection.